It is well known that cancer cells might encounter IFN-γ produced by activated T cells in the tumor's local microenvironment, and thus could respond by upregulating PD-L1 on their cell membrane to suppress T cell secretion of IL-2. This evidence concerns the gene IL2 and neoplasm.